Capvizr
THE DEAL, AT A GLANCE

Adaptyv

From the announcement
01What it doesAdaptyv is building what it calls the automated lab for agentic biology.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by Highland Europe, with ACE Ventures, ByFounders, Y Combinator doubling downFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedAdaptyv raised $40M Series A, announced 2026-08-26From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersAdaptyv's $40M Series A is a mid-market AI & Machine Learning financing in a sector with broad recent funding activity rather than an outlier round-size signal.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Adaptyv · Financing Record

Explore source-linked visual explanations for Adaptyv. Unsupported claims are withheld while source review continues.

Record 11035 · Recorded date: 2026-08-26

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime